Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. ✅
Go to Publication ✅
Clinical nutrition (Edinburgh, Scotland) (Clin Nutr ) Vol: 32 Issue 6 Pages: 935-40 Pub: 2013 Dec Epub: 2013 Mar 4 Authors Larsen N , Vogensen FK , Gøbel RJ , Michaelsen KF , Forssten SD , Lahtinen SJ , Jakobsen M , |
|
|
Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model. ✅
Go to Publication ✅
Journal of microbiology (Seoul, Korea) (J Microbiol ) Vol: 53 Issue 6 Pages: 398-405 Pub: 2015 Jun Epub: 2015 May 30 Authors Zhang M , Fan X , Fang B , Zhu C , Zhu J , Ren F , |
|
|
In vitro and in vivo anti-microbial activity evaluation of inactivated cells of Lactobacillus salivarius CECT 5713 against Streptococcus mutans. ✅
Go to Publication ✅
Archives of oral biology (Arch Oral Biol ) Vol: 84 Issue Pages: 58-63 Pub: 2017 Dec Epub: 2017 Sep 19 Authors Sañudo AI , Luque R , Díaz-Ropero MP , Fonollá J , Bañuelos Ó , |
|
|
In vitro and in vivo anti-microbial activity evaluation of inactivated cells of Lactobacillus salivarius CECT 5713 against Streptococcus mutans. ✅
Go to Publication ✅
Archives of oral biology (Arch Oral Biol ) Vol: 84 Issue Pages: 58-63 Pub: 2017 Dec Epub: 2017 Sep 19 Authors Sañudo AI , Luque R , Díaz-Ropero MP , Fonollá J , Bañuelos Ó , |
|
|
In vitro and in vivo anti-microbial activity evaluation of inactivated cells of Lactobacillus salivarius CECT 5713 against Streptococcus mutans. ✅
Go to Publication ✅
Archives of oral biology (Arch Oral Biol ) Vol: 84 Issue Pages: 58-63 Pub: 2017 Dec Epub: 2017 Sep 19 Authors Sañudo AI , Luque R , Díaz-Ropero MP , Fonollá J , Bañuelos Ó , |
|
|
Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 2 Pages: e31113 Pub: 2012 Epub: 2012 Feb 17 Authors Riboulet-Bisson E , Sturme MH , Jeffery IB , O`Donnell MM , Neville BA , Forde BM , Claesson MJ , Harris H , Gardiner GE , Casey PG , Lawlor PG , O`Toole PW , Ross RP , |
|
|
Treatment of atopic dermatitis eczema with a high concentration of Lactobacillus salivarius LS01 associated with an innovative gelling complex: a pilot study on adults. ✅
Go to Publication ✅
Journal of clinical gastroenterology (J Clin Gastroenterol ) Vol: 48 Suppl 1 Issue Pages: S47-51 Pub: 2014 Nov-Dec Epub: Authors Drago L , De Vecchi E , Toscano M , Vassena C , Altomare G , Pigatto P , |
|
|
Lactobacillus salivarius LI01 encapsulated in alginate-pectin microgels ameliorates D-galactosamine-induced acute liver injury in rats. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 17 Pages: 7437-7455 Pub: 2020 Sep Epub: 2020 Jul 14 Authors Zhuge A , Li B , Yuan Y , Lv L , Li Y , Wu J , Yang L , Bian X , Wang K , Wang Q , Yan R , Zhu X , Li L , |
|
|
Candidate-Probiotic Lactobacilli and Their Postbiotics as Health-Benefit Promoters. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 9 Pages: Pub: 2024 Sep 19 Epub: 2024 Sep 19 Authors Dobreva L , Atanasova N , Donchev P , Krumova E , Abrashev R , Karakirova Y , Mladenova R , Tolchkov V , Ralchev N , Dishliyska V , Danova S , |
|
|
Candidate-Probiotic Lactobacilli and Their Postbiotics as Health-Benefit Promoters. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 9 Pages: Pub: 2024 Sep 19 Epub: 2024 Sep 19 Authors Dobreva L , Atanasova N , Donchev P , Krumova E , Abrashev R , Karakirova Y , Mladenova R , Tolchkov V , Ralchev N , Dishliyska V , Danova S , |
|
|
Ligilactobacillus Salivarius improve body growth and anti-oxidation capacity of broiler chickens via regulation of the microbiota-gut-brain axis. ✅
Go to Publication ✅
BMC microbiology (BMC Microbiol ) Vol: 23 Issue 1 Pages: 395 Pub: 2023 Dec 9 Epub: 2023 Dec 9 Authors Yang J , Wang J , Liu Z , Chen J , Jiang J , Zhao M , Gong D , |
|
|
Lactobacillus salivarius alleviated dextran sulfate sodium (DSS)-induced colitis in mice by mitigating oxidative stress and inflammatory responses through modulation of the intestinal flora. ✅
Go to Publication ✅
Microbial pathogenesis (Microb Pathog ) Vol: 205 Issue Pages: 107696 Pub: 2025 May 10 Epub: 2025 May 10 Authors Ma J , Wu D , Xu C , He Q , Wang M , Imran M , Nazar M , Li K , |
|
|
Lactobacillus salivarius alleviated dextran sulfate sodium (DSS)-induced colitis in mice by mitigating oxidative stress and inflammatory responses through modulation of the intestinal flora. ✅
Go to Publication ✅
Microbial pathogenesis (Microb Pathog ) Vol: 205 Issue Pages: 107696 Pub: 2025 May 10 Epub: 2025 May 10 Authors Ma J , Wu D , Xu C , He Q , Wang M , Imran M , Nazar M , Li K , |
|
|
Lactobacillus salivarius alleviated dextran sulfate sodium (DSS)-induced colitis in mice by mitigating oxidative stress and inflammatory responses through modulation of the intestinal flora. ✅
Go to Publication ✅
Microbial pathogenesis (Microb Pathog ) Vol: 205 Issue Pages: 107696 Pub: 2025 May 10 Epub: 2025 May 10 Authors Ma J , Wu D , Xu C , He Q , Wang M , Imran M , Nazar M , Li K , |
|
|
Lactobacillus salivarius alleviated dextran sulfate sodium (DSS)-induced colitis in mice by mitigating oxidative stress and inflammatory responses through modulation of the intestinal flora. ✅
Go to Publication ✅
Microbial pathogenesis (Microb Pathog ) Vol: 205 Issue Pages: 107696 Pub: 2025 May 10 Epub: 2025 May 10 Authors Ma J , Wu D , Xu C , He Q , Wang M , Imran M , Nazar M , Li K , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
